| Paul S Sherbondy, MD | |
|
1850 E Park Ave, Ste 112, State College, PA 16803-6706 | |
| (814) 865-3566 | |
| (814) 863-7803 |
| Full Name | Paul S Sherbondy |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 30 Years |
| Location | 1850 E Park Ave, State College, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275597270 | NPI | - | NPPES |
| 0018163950001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | MD071095L (Pennsylvania) | Secondary |
| 207X00000X | Orthopaedic Surgery | MD071095L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Nittany Medical Center | State college, PA | Hospital |
| Milton S Hershey Medical Center | Hershey, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoenix Rehabilitation And Health Services Inc | 3476464298 | 51 |
| The Milton S Hershey Medical Center Physicians Group | 3870405483 | 1400 |
News Archive
A new study has revealed that sugary drinks or drinks that are artificially sweetened (SSB or sugar sweetened beverages) are bad for heart health. Drinking two or more of these drinks per day can lead to a 31 percent raised risk of early death due to heart disease explain the researchers.
Ligand Pharmaceuticals Incorporated announced today that it has received a $1 million milestone payment from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that expired on December 31, 2009.
New experiments on mice show, that mouse mothers can protect their pups from developing type 1 diabetes by eating a gluten-free diet. According to preliminary studies by reseachers at the University of Copenhagen, the findings may apply to humans.
Research from the University of Reading suggests that two glasses of Champagne a day may be good for your heart and circulation. The researchers have found that drinking Champagne wine daily in moderate amounts causes improvements in the way blood vessels function.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
› Verified 2 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
A new study has revealed that sugary drinks or drinks that are artificially sweetened (SSB or sugar sweetened beverages) are bad for heart health. Drinking two or more of these drinks per day can lead to a 31 percent raised risk of early death due to heart disease explain the researchers.
Ligand Pharmaceuticals Incorporated announced today that it has received a $1 million milestone payment from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that expired on December 31, 2009.
New experiments on mice show, that mouse mothers can protect their pups from developing type 1 diabetes by eating a gluten-free diet. According to preliminary studies by reseachers at the University of Copenhagen, the findings may apply to humans.
Research from the University of Reading suggests that two glasses of Champagne a day may be good for your heart and circulation. The researchers have found that drinking Champagne wine daily in moderate amounts causes improvements in the way blood vessels function.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul S Sherbondy, MD Po Box 858, Mc A410, Hershey, PA 17033-0858 Ph: (800) 243-1455 | Paul S Sherbondy, MD 1850 E Park Ave, Ste 112, State College, PA 16803-6706 Ph: (814) 865-3566 |
News Archive
A new study has revealed that sugary drinks or drinks that are artificially sweetened (SSB or sugar sweetened beverages) are bad for heart health. Drinking two or more of these drinks per day can lead to a 31 percent raised risk of early death due to heart disease explain the researchers.
Ligand Pharmaceuticals Incorporated announced today that it has received a $1 million milestone payment from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that expired on December 31, 2009.
New experiments on mice show, that mouse mothers can protect their pups from developing type 1 diabetes by eating a gluten-free diet. According to preliminary studies by reseachers at the University of Copenhagen, the findings may apply to humans.
Research from the University of Reading suggests that two glasses of Champagne a day may be good for your heart and circulation. The researchers have found that drinking Champagne wine daily in moderate amounts causes improvements in the way blood vessels function.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
› Verified 2 days ago
Dr. Dov A Bader, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave, Suite 112, State College, PA 16803 Phone: 814-865-3566 Fax: 814-863-7803 | |
Dr. Edwin J Rogusky, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Regent Ct, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
Thomas J Ellis, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Regent Ct, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
Dr. Christopher J. Lincoski, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Regent Ct, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
James S Martin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Old Gatesburg Rd Ste 200, State College, PA 16803 Phone: 814-237-4321 Fax: 814-235-0484 | |
Kenneth L Cherry, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 476 Rolling Drive Drive, Suite 200, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
Paul K Herickhoff, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave Ste 112, State College, PA 16803 Phone: 814-865-3566 Fax: 814-863-7803 |